Treace Medical Concepts, Inc. (TMCI) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
TMCI EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TMCI Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 79.8% | -25.5% | -27.7% |
| 2024 | 80.4% | -26.6% | -26.6% |
| 2023 | 81.2% | -27.5% | -26.5% |
| 2022 | 80.6% | -24.6% | -30.2% |
| 2021 | 82.1% | -17.5% | -21.8% |
Download Data
Export TMCI earnings history in CSV or JSON format
Free sign-in required to download data
Treace Medical Concepts, Inc. (TMCI) Earnings Overview
As of May 8, 2026, Treace Medical Concepts, Inc. (TMCI) reported trailing twelve-month net income of -$59M, reflecting -3.3% year-over-year growth. The company earned $-0.92 per diluted share over the past four quarters, with a net profit margin of -27.7%.
Looking at the long-term picture, TMCI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2020.
Treace Medical Concepts, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ANGO (-$28M net income, -11.6% margin), NVCR (-$173M net income, -20.8% margin), ATEC (-$125M net income, -18.8% margin), TMCI has room to improve margins relative to the peer group. Compare TMCI vs ANGO →
TMCI Earnings vs Peers
Earnings metrics vs comparable public companies
TMCI Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$59M | -5.8% | -$54M | $-0.93 | -27.7% | -25.5% |
| 2024 | -$56M | -12.6% | -$56M | $-0.90 | -26.6% | -26.6% |
| 2023 | -$50M | -15.7% | -$51M | $-0.81 | -26.5% | -27.5% |
| 2022 | -$43M | -108.3% | -$35M | $-0.77 | -30.2% | -24.6% |
| 2021 | -$21M | -460.3% | -$17M | $-0.38 | -21.8% | -17.5% |
| 2020 | -$4M | +14.0% | $855,000 | $-0.08 | -6.4% | 1.5% |
| 2019 | -$4M | - | -$4M | $-0.10 | -10.8% | -9.0% |
See TMCI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TMCI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TMCI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTMCI — Frequently Asked Questions
Quick answers to the most common questions about buying TMCI stock.
Is TMCI growing earnings?
TMCI EPS of $-0.92 reflects slowing growth at -3.3%, below the 5-year CAGR of N/A. TTM net income is $-59M. Expansion rate has moderated.
What are TMCI's profit margins?
Treace Medical Concepts, Inc. net margin is -27.7%, with operating margin at -25.5%. Below-average margins reflect competitive or cost pressures.
How consistent are TMCI's earnings?
TMCI earnings data spans 2019-2025. The current earnings trend is -3.3% YoY. Historical data enables comparison across business cycles.